Attralus to Present New Data on Its Amyloidosis Portfolio
SAN FRANCISCO, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to...
Source: globenewswire.com
Stay updated with breaking news from Jonathan Wall. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SAN FRANCISCO, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to...
AROUND THE COUNTRY: Silver View lands the spoils in Louisburgh 2022-07-22
Bryson DeChambeau's partnership with Brid
There is no larger gathering of the hockey community than the NHL Draft.
AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosisAT-01 visualizes and quantifies organ-specific...